Pre-order Enquiry
Request Free Sample
Global Live Attenuated Vaccines Market Research Report 2022(Status and Outlook)
SKU ID : BOS-21146231 | Publishing Date : 22-Jun-2022 | No. of pages : 106
Detailed TOC of Global Live Attenuated Vaccines Market Research Report 2022(Status and Outlook)
TABLE OF CONTENTS1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Live Attenuated Vaccines
1.2 Key Market Segments
1.2.1 Live Attenuated Vaccines Segment by Type
1.2.2 Live Attenuated Vaccines Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Live Attenuated Vaccines Market Overview
2.1 Global Market Overview
2.1.1 Global Live Attenuated Vaccines Market Size (M USD) Estimates and Forecasts (2017-2028)
2.1.2 Global Live Attenuated Vaccines Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Live Attenuated Vaccines Market Competitive Landscape
3.1 Global Live Attenuated Vaccines Sales by Manufacturers (2017-2022)
3.2 Global Live Attenuated Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.3 Live Attenuated Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Live Attenuated Vaccines Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Live Attenuated Vaccines Sales Sites, Area Served, Product Type
3.6 Live Attenuated Vaccines Market Competitive Situation and Trends
3.6.1 Live Attenuated Vaccines Market Concentration Rate
3.6.2 Global 5 and 10 Largest Live Attenuated Vaccines Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Live Attenuated Vaccines Industry Chain Analysis
4.1 Live Attenuated Vaccines Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Live Attenuated Vaccines Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Live Attenuated Vaccines Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Live Attenuated Vaccines Sales Market Share by Type (2017-2022)
6.3 Global Live Attenuated Vaccines Market Size Market Share by Type (2017-2022)
6.4 Global Live Attenuated Vaccines Price by Type (2017-2022)
7 Live Attenuated Vaccines Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Live Attenuated Vaccines Market Sales by Application (2017-2022)
7.3 Global Live Attenuated Vaccines Market Size (M USD) by Application (2017-2022)
7.4 Global Live Attenuated Vaccines Sales Growth Rate by Application (2017-2022)
8 Live Attenuated Vaccines Market Segmentation by Region
8.1 Global Live Attenuated Vaccines Sales by Region
8.1.1 Global Live Attenuated Vaccines Sales by Region
8.1.2 Global Live Attenuated Vaccines Sales Market Share by Region
8.2 North America
8.2.1 North America Live Attenuated Vaccines Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Live Attenuated Vaccines Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Live Attenuated Vaccines Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Live Attenuated Vaccines Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Live Attenuated Vaccines Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profiled
9.1 GlaxoSmithKline
9.1.1 GlaxoSmithKline Live Attenuated Vaccines Basic Information
9.1.2 GlaxoSmithKline Live Attenuated Vaccines Product Overview
9.1.3 GlaxoSmithKline Live Attenuated Vaccines Product Market Performance
9.1.4 GlaxoSmithKline Business Overview
9.1.5 GlaxoSmithKline Live Attenuated Vaccines SWOT Analysis
9.1.6 GlaxoSmithKline Recent Developments
9.2 Merck
9.2.1 Merck Live Attenuated Vaccines Basic Information
9.2.2 Merck Live Attenuated Vaccines Product Overview
9.2.3 Merck Live Attenuated Vaccines Product Market Performance
9.2.4 Merck Business Overview
9.2.5 Merck Live Attenuated Vaccines SWOT Analysis
9.2.6 Merck Recent Developments
9.3 Pfizer
9.3.1 Pfizer Live Attenuated Vaccines Basic Information
9.3.2 Pfizer Live Attenuated Vaccines Product Overview
9.3.3 Pfizer Live Attenuated Vaccines Product Market Performance
9.3.4 Pfizer Business Overview
9.3.5 Pfizer Live Attenuated Vaccines SWOT Analysis
9.3.6 Pfizer Recent Developments
9.4 Astellas Pharma
9.4.1 Astellas Pharma Live Attenuated Vaccines Basic Information
9.4.2 Astellas Pharma Live Attenuated Vaccines Product Overview
9.4.3 Astellas Pharma Live Attenuated Vaccines Product Market Performance
9.4.4 Astellas Pharma Business Overview
9.4.5 Astellas Pharma Live Attenuated Vaccines SWOT Analysis
9.4.6 Astellas Pharma Recent Developments
9.5 Johnson and Johnson
9.5.1 Johnson and Johnson Live Attenuated Vaccines Basic Information
9.5.2 Johnson and Johnson Live Attenuated Vaccines Product Overview
9.5.3 Johnson and Johnson Live Attenuated Vaccines Product Market Performance
9.5.4 Johnson and Johnson Business Overview
9.5.5 Johnson and Johnson Live Attenuated Vaccines SWOT Analysis
9.5.6 Johnson and Johnson Recent Developments
9.6 CSL
9.6.1 CSL Live Attenuated Vaccines Basic Information
9.6.2 CSL Live Attenuated Vaccines Product Overview
9.6.3 CSL Live Attenuated Vaccines Product Market Performance
9.6.4 CSL Business Overview
9.6.5 CSL Recent Developments
9.7 Sanofi
9.7.1 Sanofi Live Attenuated Vaccines Basic Information
9.7.2 Sanofi Live Attenuated Vaccines Product Overview
9.7.3 Sanofi Live Attenuated Vaccines Product Market Performance
9.7.4 Sanofi Business Overview
9.7.5 Sanofi Recent Developments
9.8 Serum Institute Of India
9.8.1 Serum Institute Of India Live Attenuated Vaccines Basic Information
9.8.2 Serum Institute Of India Live Attenuated Vaccines Product Overview
9.8.3 Serum Institute Of India Live Attenuated Vaccines Product Market Performance
9.8.4 Serum Institute Of India Business Overview
9.8.5 Serum Institute Of India Recent Developments
10 Live Attenuated Vaccines Market Forecast by Region
10.1 Global Live Attenuated Vaccines Market Size Forecast
10.2 Global Live Attenuated Vaccines Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Live Attenuated Vaccines Market Size Forecast by Country
10.2.3 Asia Pacific Live Attenuated Vaccines Market Size Forecast by Region
10.2.4 South America Live Attenuated Vaccines Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Live Attenuated Vaccines by Country
11 Forecast Market by Type and by Application (2022-2028)
11.1 Global Live Attenuated Vaccines Market Forecast by Type (2022-2028)
11.1.1 Global Forecasted Sales of Live Attenuated Vaccines by Type (2022-2028)
11.1.2 Global Live Attenuated Vaccines Market Size Forecast by Type (2022-2028)
11.1.3 Global Forecasted Price of Live Attenuated Vaccines by Type (2022-2028)
11.2 Global Live Attenuated Vaccines Market Forecast by Application (2022-2028)
11.2.1 Global Live Attenuated Vaccines Sales (K Units) Forecast by Application
11.2.2 Global Live Attenuated Vaccines Market Size (M USD) Forecast by Application (2022-2028)
12 Conclusion and Key Findings
List of Figures, Tables and Charts Available in Global Live Attenuated Vaccines Market Research Report 2022(Status and Outlook)
LIST OF TABLESTable 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Live Attenuated Vaccines Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Live Attenuated Vaccines Sales (K Units) by Manufacturers (2017-2022)
Table 6. Global Live Attenuated Vaccines Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Live Attenuated Vaccines Revenue (M USD) by Manufacturers (2017-2022)
Table 8. Global Live Attenuated Vaccines Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Attenuated Vaccines as of 2021)
Table 10. Global Market Live Attenuated Vaccines Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Live Attenuated Vaccines Sales Sites and Area Served
Table 12. Manufacturers Live Attenuated Vaccines Product Type
Table 13. Global Live Attenuated Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Live Attenuated Vaccines
Table 16. Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Live Attenuated Vaccines Market Challenges
Table 22. Market Restraints
Table 23. Global Live Attenuated Vaccines Sales by Type (K Units)
Table 24. Global Live Attenuated Vaccines Market Size by Type (M USD)
Table 25. Global Live Attenuated Vaccines Sales (K Units) by Type (2017-2022)
Table 26. Global Live Attenuated Vaccines Sales Market Share by Type (2017-2022)
Table 27. Global Live Attenuated Vaccines Market Size (M USD) by Type (2017-2022)
Table 28. Global Live Attenuated Vaccines Market Size Share by Type (2017-2022)
Table 29. Global Live Attenuated Vaccines Price (USD/Unit) by Type (2017-2022)
Table 30. Global Live Attenuated Vaccines Sales (K Units) by Application
Table 31. Global Live Attenuated Vaccines Market Size by Application
Table 32. Global Live Attenuated Vaccines Sales by Application (2017-2022) & (K Units)
Table 33. Global Live Attenuated Vaccines Sales Market Share by Application (2017-2022)
Table 34. Global Live Attenuated Vaccines Sales by Application (2017-2022) & (M USD)
Table 35. Global Live Attenuated Vaccines Market Share by Application (2017-2022)
Table 36. Global Live Attenuated Vaccines Sales Growth Rate by Application (2017-2022)
Table 37. Global Live Attenuated Vaccines Sales by Region (2017-2022) & (K Units)
Table 38. Global Live Attenuated Vaccines Sales Market Share by Region (2017-2022)
Table 39. North America Live Attenuated Vaccines Sales by Country (2017-2022) & (K Units)
Table 40. Europe Live Attenuated Vaccines Sales by Country (2017-2022) & (K Units)
Table 41. Asia Pacific Live Attenuated Vaccines Sales by Region (2017-2022) & (K Units)
Table 42. South America Live Attenuated Vaccines Sales by Country (2017-2022) & (K Units)
Table 43. Middle East and Africa Live Attenuated Vaccines Sales by Region (2017-2022) & (K Units)
Table 44. GlaxoSmithKline Live Attenuated Vaccines Basic Information
Table 45. GlaxoSmithKline Live Attenuated Vaccines Product Overview
Table 46. GlaxoSmithKline Live Attenuated Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 47. GlaxoSmithKline Business Overview
Table 48. GlaxoSmithKline Live Attenuated Vaccines SWOT Analysis
Table 49. GlaxoSmithKline Recent Developments
Table 50. Merck Live Attenuated Vaccines Basic Information
Table 51. Merck Live Attenuated Vaccines Product Overview
Table 52. Merck Live Attenuated Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 53. Merck Business Overview
Table 54. Merck Live Attenuated Vaccines SWOT Analysis
Table 55. Merck Recent Developments
Table 56. Pfizer Live Attenuated Vaccines Basic Information
Table 57. Pfizer Live Attenuated Vaccines Product Overview
Table 58. Pfizer Live Attenuated Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 59. Pfizer Business Overview
Table 60. Pfizer Live Attenuated Vaccines SWOT Analysis
Table 61. Pfizer Recent Developments
Table 62. Astellas Pharma Live Attenuated Vaccines Basic Information
Table 63. Astellas Pharma Live Attenuated Vaccines Product Overview
Table 64. Astellas Pharma Live Attenuated Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Astellas Pharma Business Overview
Table 66. Astellas Pharma Live Attenuated Vaccines SWOT Analysis
Table 67. Astellas Pharma Recent Developments
Table 68. Johnson and Johnson Live Attenuated Vaccines Basic Information
Table 69. Johnson and Johnson Live Attenuated Vaccines Product Overview
Table 70. Johnson and Johnson Live Attenuated Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 71. Johnson and Johnson Business Overview
Table 72. Johnson and Johnson Live Attenuated Vaccines SWOT Analysis
Table 73. Johnson and Johnson Recent Developments
Table 74. CSL Live Attenuated Vaccines Basic Information
Table 75. CSL Live Attenuated Vaccines Product Overview
Table 76. CSL Live Attenuated Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. CSL Business Overview
Table 78. CSL Recent Developments
Table 79. Sanofi Live Attenuated Vaccines Basic Information
Table 80. Sanofi Live Attenuated Vaccines Product Overview
Table 81. Sanofi Live Attenuated Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Sanofi Business Overview
Table 83. Sanofi Recent Developments
Table 84. Serum Institute Of India Live Attenuated Vaccines Basic Information
Table 85. Serum Institute Of India Live Attenuated Vaccines Product Overview
Table 86. Serum Institute Of India Live Attenuated Vaccines Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Serum Institute Of India Business Overview
Table 88. Serum Institute Of India Recent Developments
Table 89. Global Live Attenuated Vaccines Sales Forecast by Region (K Units)
Table 90. Global Live Attenuated Vaccines Market Size Forecast by Region (M USD)
Table 91. North America Live Attenuated Vaccines Sales Forecast by Country (2022-2028) & (K Units)
Table 92. North America Live Attenuated Vaccines Market Size Forecast by Country (2022-2028) & (M USD)
Table 93. Europe Live Attenuated Vaccines Sales Forecast by Country (2022-2028) & (K Units)
Table 94. Europe Live Attenuated Vaccines Market Size Forecast by Country (2022-2028) & (M USD)
Table 95. Asia Pacific Live Attenuated Vaccines Sales Forecast by Region (2022-2028) & (K Units)
Table 96. Asia Pacific Live Attenuated Vaccines Market Size Forecast by Region (2022-2028) & (M USD)
Table 97. South America Live Attenuated Vaccines Sales Forecast by Country (2022-2028) & (K Units)
Table 98. South America Live Attenuated Vaccines Market Size Forecast by Country (2022-2028) & (M USD)
Table 99. Middle East and Africa Live Attenuated Vaccines Consumption Forecast by Country (2022-2028) & (Units)
Table 100. Middle East and Africa Live Attenuated Vaccines Market Size Forecast by Country (2022-2028) & (M USD)
Table 101. Global Live Attenuated Vaccines Sales Forecast by Type (2022-2028) & (K Units)
Table 102. Global Live Attenuated Vaccines Market Size Forecast by Type (2022-2028) & (M USD)
Table 103. Global Live Attenuated Vaccines Price Forecast by Type (2022-2028) & (USD/Unit)
Table 104. Global Live Attenuated Vaccines Sales (K Units) Forecast by Application (2022-2028)
Table 105. Global Live Attenuated Vaccines Market Size Forecast by Application (2022-2028) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Live Attenuated Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Live Attenuated Vaccines Market Size (M USD), 2017-2028
Figure 5. Global Live Attenuated Vaccines Market Size (M USD) (2017-2028)
Figure 6. Global Live Attenuated Vaccines Sales (K Units) & (2017-2028)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Live Attenuated Vaccines Market Size (M USD) by Country (M USD)
Figure 11. Live Attenuated Vaccines Sales Share by Manufacturers in 2020
Figure 12. Global Live Attenuated Vaccines Revenue Share by Manufacturers in 2020
Figure 13. Live Attenuated Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 14. Global Market Live Attenuated Vaccines Average Price (USD/Unit) of Key Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Players: Market Share by Live Attenuated Vaccines Revenue in 2021
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Live Attenuated Vaccines Market Share by Type
Figure 18. Sales Market Share of Live Attenuated Vaccines by Type (2017-2022)
Figure 19. Sales Market Share of Live Attenuated Vaccines by Type in 2021
Figure 20. Market Size Share of Live Attenuated Vaccines by Type (2017-2022)
Figure 21. Market Size Market Share of Live Attenuated Vaccines by Type in 2020
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Live Attenuated Vaccines Market Share by Application
Figure 24. Global Live Attenuated Vaccines Sales Market Share by Application (2017-2022)
Figure 25. Global Live Attenuated Vaccines Sales Market Share by Application in 2021
Figure 26. Global Live Attenuated Vaccines Market Share by Application (2017-2022)
Figure 27. Global Live Attenuated Vaccines Market Share by Application in 2020
Figure 28. Global Live Attenuated Vaccines Sales Growth Rate by Application (2017-2022)
Figure 29. Global Live Attenuated Vaccines Sales Market Share by Region (2017-2022)
Figure 30. North America Live Attenuated Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 31. North America Live Attenuated Vaccines Sales Market Share by Country in 2020
Figure 32. U.S. Live Attenuated Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 33. Canada Live Attenuated Vaccines Sales (K Units) and Growth Rate (2017-2022)
Figure 34. Mexico Live Attenuated Vaccines Sales (Units) and Growth Rate (2017-2022)
Figure 35. Europe Live Attenuated Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 36. Europe Live Attenuated Vaccines Sales Market Share by Country in 2020
Figure 37. Germany Live Attenuated Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 38. France Live Attenuated Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 39. U.K. Live Attenuated Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 40. Italy Live Attenuated Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 41. Russia Live Attenuated Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 42. Asia Pacific Live Attenuated Vaccines Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Live Attenuated Vaccines Sales Market Share by Region in 2020
Figure 44. China Live Attenuated Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 45. Japan Live Attenuated Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 46. South Korea Live Attenuated Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 47. India Live Attenuated Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 48. Southeast Asia Live Attenuated Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 49. South America Live Attenuated Vaccines Sales and Growth Rate (K Units)
Figure 50. South America Live Attenuated Vaccines Sales Market Share by Country in 2020
Figure 51. Brazil Live Attenuated Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 52. Argentina Live Attenuated Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 53. Columbia Live Attenuated Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 54. Middle East and Africa Live Attenuated Vaccines Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Live Attenuated Vaccines Sales Market Share by Region in 2020
Figure 56. Saudi Arabia Live Attenuated Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 57. UAE Live Attenuated Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 58. Egypt Live Attenuated Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 59. Nigeria Live Attenuated Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 60. South Africa Live Attenuated Vaccines Sales and Growth Rate (2017-2022) & (K Units)
Figure 61. Global Live Attenuated Vaccines Sales Forecast by Volume (2017-2028) & (K Units)
Figure 62. Global Live Attenuated Vaccines Market Size Forecast by Value (2017-2028) & (M USD)
Figure 63. Global Live Attenuated Vaccines Sales Market Share Forecast by Type (2022-2028)
Figure 64. Global Live Attenuated Vaccines Market Share Forecast by Type (2022-2028)
Figure 65. Global Live Attenuated Vaccines Sales Forecast by Application (2022-2028)
Figure 66. Global Live Attenuated Vaccines Market Share Forecast by Application (2022-2028)
Keyplayers in Global Live Attenuated Vaccines Market Research Report 2022(Status and Outlook)
•GlaxoSmithKline•Merck
•Pfizer
•Astellas Pharma
•Johnson and Johnson
•CSL
•Sanofi
•Serum Institute Of India
Request Sample
Request Discount
